Stryker [SYK] vs Medtronic plc [MDT] Detailed Stock Comparison

Stryker

Medtronic plc
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Stryker wins in 8 metrics, Medtronic plc wins in 12 metrics, with 0 ties. Medtronic plc appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Stryker | Medtronic plc | Better |
---|---|---|---|
P/E Ratio (TTM) | 49.37 | 26.03 | Medtronic plc |
Price-to-Book Ratio | 6.73 | 2.52 | Medtronic plc |
Debt-to-Equity Ratio | 80.83 | 59.44 | Medtronic plc |
PEG Ratio | 7.14 | 16.11 | Stryker |
EV/EBITDA | 24.93 | 14.99 | Medtronic plc |
Profit Margin (TTM) | 12.25% | 13.63% | Medtronic plc |
Operating Margin (TTM) | 21.95% | 18.69% | Stryker |
EBITDA Margin (TTM) | 21.95% | 18.69% | Stryker |
Return on Equity | 14.25% | 9.74% | Stryker |
Return on Assets (TTM) | 7.74% | 4.57% | Stryker |
Free Cash Flow (TTM) | $3.49B | $5.19B | Medtronic plc |
Dividend Yield | 0.88% | 3.27% | Medtronic plc |
1-Year Return | 2.30% | 5.58% | Medtronic plc |
Price-to-Sales Ratio (TTM) | 5.99 | 3.53 | Medtronic plc |
Enterprise Value | $159.26B | $141.58B | Stryker |
EV/Revenue Ratio | 6.69 | 4.14 | Medtronic plc |
Gross Profit Margin (TTM) | 63.78% | 65.02% | Medtronic plc |
Revenue per Share (TTM) | $62 | $27 | Stryker |
Earnings per Share (Diluted) | $7.56 | $3.62 | Stryker |
Beta (Stock Volatility) | 0.93 | 0.79 | Medtronic plc |
Stryker vs Medtronic plc Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Stryker | -0.71% | -2.45% | -5.71% | -6.03% | -1.15% | 2.75% |
Medtronic plc | -1.50% | -1.35% | 2.46% | 9.69% | 6.45% | 17.55% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Stryker | 2.30% | 81.97% | 76.94% | 282.10% | 636.99% | 645.64% |
Medtronic plc | 5.58% | 16.78% | -7.51% | 32.57% | 180.40% | 75.87% |
News Based Sentiment: Stryker vs Medtronic plc
Stryker
News based Sentiment: MIXED
September presented a mixed bag for Stryker investors. While the company delivered strong Q2 results and launched a promising new product, continued insider selling and cautious analyst ratings create uncertainty. The anticipated revenue decline for FY25 adds another layer of complexity, making it a significant month for the company's investment narrative.
Medtronic plc
News based Sentiment: POSITIVE
September was a strong month for Medtronic, marked by a significant earnings beat, raised guidance, and strategic investments in growth areas like India and the approval of the Altaviva™ device. These developments demonstrate the company's strong execution and commitment to shareholder value, positioning it favorably for future growth.
Performance & Financial Health Analysis: Stryker vs Medtronic plc
Metric | SYK | MDT |
---|---|---|
Market Information | ||
Market Cap | $142.80B | $120.85B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 1,148,919 | 8,517,600 |
90 Day Avg. Volume | 1,112,163 | 7,675,703 |
Last Close | $368.57 | $94.30 |
52 Week Range | $329.16 - $406.19 | $79.29 - $96.25 |
% from 52W High | -9.26% | -2.03% |
All-Time High | $406.19 (Jan 27, 2025) | $135.89 (Sep 06, 2021) |
% from All-Time High | -9.26% | -30.61% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.11% | 0.08% |
Quarterly Earnings Growth | 0.07% | 0.00% |
Financial Health | ||
Profit Margin (TTM) | 0.12% | 0.14% |
Operating Margin (TTM) | 0.22% | 0.19% |
Return on Equity (TTM) | 0.14% | 0.10% |
Debt to Equity (MRQ) | 80.83 | 59.44 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $55.43 | $37.36 |
Cash per Share (MRQ) | $6.45 | $6.33 |
Operating Cash Flow (TTM) | $4.77B | $7.15B |
Levered Free Cash Flow (TTM) | $3.49B | $4.46B |
Dividends | ||
Last 12-Month Dividend Yield | 0.88% | 3.27% |
Last 12-Month Dividend | $3.28 | $2.80 |
Valuation & Enterprise Metrics Analysis: Stryker vs Medtronic plc
Metric | SYK | MDT |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 49.37 | 26.03 |
Forward P/E | 27.59 | 16.11 |
PEG Ratio | 7.14 | 16.11 |
Price to Sales (TTM) | 5.99 | 3.53 |
Price to Book (MRQ) | 6.73 | 2.52 |
Market Capitalization | ||
Market Capitalization | $142.80B | $120.85B |
Enterprise Value | $159.26B | $141.58B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 6.69 | 4.14 |
Enterprise to EBITDA | 24.93 | 14.99 |
Risk & Other Metrics | ||
Beta | 0.93 | 0.79 |
Book Value per Share (MRQ) | $55.43 | $37.36 |
Financial Statements Comparison: Stryker vs Medtronic plc
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | SYK | MDT |
---|---|---|
Revenue/Sales | $6.02B | $8.58B |
Cost of Goods Sold | $2.18B | $3.00B |
Gross Profit | $3.84B | $5.58B |
Research & Development | $407.00M | $726.00M |
Operating Income (EBIT) | $1.17B | $1.52B |
EBITDA | $1.52B | $2.30B |
Pre-Tax Income | $1.02B | $1.30B |
Income Tax | $132.00M | $255.00M |
Net Income (Profit) | $884.00M | $1.05B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | SYK | MDT |
---|---|---|
Cash & Equivalents | $2.32B | $2.22B |
Total Current Assets | $13.02B | $23.81B |
Total Current Liabilities | $7.93B | $12.88B |
Long-Term Debt | $14.38B | $25.64B |
Total Shareholders Equity | $20.93B | $48.26B |
Retained Earnings | $18.86B | $31.48B |
Property, Plant & Equipment | $1.67B | $7.16B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | SYK | MDT |
---|---|---|
Operating Cash Flow | $719.00M | $2.14B |
Capital Expenditures | $-123.00M | $-459.00M |
Free Cash Flow | $127.00M | $2.07B |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | $-274.00M |
Short Interest & Institutional Ownership Analysis
Metric | SYK | MDT |
---|---|---|
Shares Short | 4.19M | 12.79M |
Short Ratio | 3.30 | 1.78 |
Short % of Float | 0.01% | 0.01% |
Average Daily Volume (10 Day) | 1,148,919 | 8,517,600 |
Average Daily Volume (90 Day) | 1,112,163 | 7,675,703 |
Shares Outstanding | 381.40M | 1.28B |
Float Shares | 344.60M | 1.28B |
% Held by Insiders | 0.05% | 0.00% |
% Held by Institutions | 0.82% | 0.87% |
Dividend Analysis & Yield Comparison: Stryker vs Medtronic plc
Metric | SYK | MDT |
---|---|---|
Last 12-Month Dividend | $3.28 | $2.80 |
Last 12-Month Dividend Yield | 0.88% | 3.27% |
3-Year Avg Annual Dividend | $3.09 | $2.76 |
3-Year Avg Dividend Yield | 0.27% | 0.83% |
3-Year Total Dividends | $9.26 | $8.28 |
Ex-Dividend Date | Mar 31, 2025 | Mar 28, 2025 |